NCT00126646 2010-06-22
BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma
MedImmune LLC
Phase 1 Completed
Clinical Trials
1 trialsCompleted × Leukemia, Lymphocytic, Chronic, B-Cell × RFB4(dsFv)-PE38 recombinant immunotoxin × Clear all